Diplomat Pharmacy

At Diplomat, we blend clinical excellence with a personal touch, providing medications and support to people with serious long-term diseases, including cancer, multiple sclerosis, HIV and rheumatoid arthritis. Through our partnerships, we offer specialty care in retail pharmacies across the U.S. and grant specialty-care coverage to millions of lives nationwide. Our defining belief is simple; it’s been the same since we started in 1975: “Take good care of patients, and the rest falls into place.” Today, that tradition continues, one patient at a time, with satisfaction rates between 98 and 99 percent.
Company Growth (employees)
Type
Public
HQ
Flint, US
Founded
1975
Size (employees)
1,737 (est)
Diplomat Pharmacy was founded in 1975 and is headquartered in Flint, US

Diplomat Pharmacy Office Locations

Diplomat Pharmacy has an office in Flint
Flint, US (HQ)
4100 S Saginaw P. O. Box 321130

Diplomat Pharmacy Data and Metrics

Diplomat Pharmacy Financial Metrics

Diplomat Pharmacy's revenue was reported to be $1.1 b in Q1, 2017
USD

Revenue (Q1, 2017)

1.1 b

Gross profit (Q1, 2017)

2.1 b

Gross profit margin (Q1, 2017), %

192%

Net income (Q1, 2017)

4.2 m

EBIT (Q1, 2017)

8.5 m

Market capitalization (15-Aug-2017)

1.1 b

Cash (31-Mar-2017)

16.6 m
Diplomat Pharmacy's current market capitalization is $1.1 b.
USDFY, 2014FY, 2015FY, 2016

Revenue

2.2 b3.4 b4.4 b

Revenue growth, %

52%31%

Cost of goods sold

(2.1 b)(3.1 b)(4.1 b)

Gross profit

4.3 b6.5 b8.5 b

Gross profit Margin, %

194%192%193%

General and administrative expense

(127.6 m)(217.3 m)(277.8 m)

Operating expense total

(127.6 m)(217.3 m)(277.8 m)

EBIT

12.6 m45.9 m47.1 m

EBIT margin, %

1%1%1%

Interest expense

(2.5 m)(5.2 m)(6.6 m)

Pre tax profit

9.2 m41 m36.2 m

Income tax expense

(4.7 m)(16.2 m)(11.2 m)

Net Income

4.6 m24.8 m25 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

624.9 m808 m946.9 m995.9 m1.1 b1.2 b1.1 b

Cost of goods sold

(583.7 m)(738.3 m)(871.2 m)(916.6 m)(1 b)(1.1 b)(993.7 m)

Gross profit

1.2 b1.5 b1.8 b1.9 b2.1 b2.3 b2.1 b

Gross profit Margin, %

193%191%192%192%192%193%192%

General and administrative expense

(36.3 m)(62.5 m)(48.9 m)(54.2 m)(69.4 m)(77.1 m)(76.5 m)

Operating expense total

(36.3 m)(62.5 m)(48.9 m)(54.2 m)(69.4 m)(77.1 m)(76.5 m)

EBIT

4.8 m7.2 m26.9 m25 m13.9 m1.4 m8.5 m

EBIT margin, %

1%1%3%3%1%0%1%

Interest expense

(321 k)(1.9 m)(1.5 m)(1.4 m)(1.5 m)(1.8 m)(2 m)

Pre tax profit

4.6 m5.4 m25.5 m23.7 m12.4 m(408 k)6.5 m

Income tax expense

(2 m)(2.3 m)(9.8 m)(8.5 m)(4.1 m)3.2 m(2.3 m)

Net Income

2.7 m3.1 m15.7 m15.2 m8.3 m2.8 m4.2 m
USDFY, 2014FY, 2015FY, 2016

Cash

18 m27.6 m8 m

Accounts Receivable

158.5 m254.7 m275.6 m

Inventories

110.7 m166 m215.4 m

Current Assets

291.1 m461 m519.8 m

PP&E

13.2 m16.5 m20.4 m

Goodwill

23.1 m256.3 m316.6 m

Total Assets

390.1 m1 b1.1 b

Accounts Payable

202.5 m296.6 m320.7 m

Current Liabilities

215.4 m371.9 m385.3 m

Total Liabilities

494.2 m

Common Stock

451.6 m503.8 m

Additional Paid-in Capital

9.9 m29.2 m33.3 m

Retained Earnings

5.4 m31.1 m76.3 m

Total Equity

168.7 m515.5 m613.7 m

Financial Leverage

2.3 x2 x1.8 x
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

162 m17.3 m15.7 m14.7 m7.9 m17.1 m16.6 m

Accounts Receivable

167.5 m257.9 m258.2 m268.4 m317.2 m289.2 m255.5 m

Inventories

109.8 m159.5 m153.3 m181 m182.2 m197 m200.3 m

Current Assets

444.8 m452.7 m437.2 m492.3 m529.3 m528.8 m479.7 m

PP&E

13.6 m14.2 m15 m17.5 m19.5 m20.1 m19.9 m

Goodwill

23.1 m250.5 m253.4 m256.3 m315.4 m315.4 m336.8 m

Total Assets

544.8 m1 b984.2 m1 b1.1 b1.1 b1.1 b

Accounts Payable

198.4 m265.6 m272 m291.7 m379.5 m332 m301.4 m

Current Liabilities

212.7 m402.1 m358.5 m362.5 m424.9 m402.7 m339.2 m

Common Stock

299.9 m445.3 m448.7 m452.2 m499.5 m502.7 m507.4 m

Additional Paid-in Capital

12.3 m11.9 m21.9 m30.6 m32.1 m32.8 m33.5 m

Retained Earnings

8.2 m11.6 m27.6 m63.5 m72 m77.4 m80.7 m

Total Equity

324.7 m472.9 m502 m549.6 m606.7 m613.4 m621.7 m

Financial Leverage

1.7 x2.1 x2 x1.9 x1.9 x1.8 x1.7 x
USDFY, 2014FY, 2015FY, 2016

Net Income

4.6 m24.8 m25 m

Depreciation and Amortization

30.8 m50 m

Accounts Receivable

158.5 m(50.8 m)(15.1 m)

Inventories

110.7 m(41.7 m)(44.3 m)

Accounts Payable

202.5 m43.2 m(5.9 m)

Cash From Operating Activities

8.8 m9.6 m31.3 m

Cash From Investing Activities

(311.6 m)(86 m)

Long-term Borrowings

(3 m)(6 m)

Cash From Financing Activities

291.8 m35 m

Interest Paid

3.9 m5.3 m

Income Taxes Paid

351 k728 k
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

2.7 m3.1 m15.7 m15.2 m8.3 m2.8 m4.2 m

Accounts Receivable

167.5 m257.9 m258.2 m268.4 m317.2 m289.2 m255.5 m

Inventories

109.8 m159.5 m153.3 m181 m182.2 m197 m200.3 m

Accounts Payable

198.4 m265.6 m272 m291.7 m379.5 m332 m301.4 m
USDY, 2017

Revenue/Employee

621 k

Financial Leverage

1.7 x

Diplomat Pharmacy Market Value History

Traffic Overview of Diplomat Pharmacy

Diplomat Pharmacy Online and Social Media Presence

Diplomat Pharmacy Company Life and Culture

You may also be interested in